Myelodysplastic Syndromes (MDS) News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Robin Roberts Celebrates 5-Year Anniversary of Return to 'GMA ... - Entertainment Tonight



Entertainment Tonight
 
Robin Roberts Celebrates 5-Year Anniversary of Return to 'GMA ... 
Entertainment Tonight
Robin Roberts marked the five-year anniversary of her return to Good Morning America with an inspiring tweet on Tuesday. The television host took leave from the ABC morning show in August 2012 to undergo a bone marrow transplant to treat a rare blood ...
Robin Roberts Celebrates 5-Year Anniversary of Return to 'GMA' Following MDS Battle WHAS 11.com

all 4 news articles » 


Rutgers Cancer Institute of New Jersey recognized as Center of Excellence for work on Myelodysplastic syndromes - MyCentralJersey.com



MyCentralJersey.com
 
Rutgers Cancer Institute of New Jersey recognized as Center of Excellence for work on Myelodysplastic syndromes 
MyCentralJersey.com
NEW BRUNSWICK ? Rutgers Cancer Institute of New Jersey is now recognized as a Center of Excellence by the Myelodysplastic Syndromes (MDS) Foundation in the research, diagnosis and treatment of MDS disorders. Rutgers Cancer Institute hematologist ...

 


Therapeutic Vaccine Combination May Help Patients With Myelodysplastic Syndrome - Cancer Network



Therapeutic Vaccine Combination May Help Patients With Myelodysplastic Syndrome 
Cancer Network
In the current study, the researchers enrolled nine MDS patients who received an HLA unrestricted NY-ESO-1 vaccine (CDX-1401 + poly-ICLC). The subjects received the vaccine in a non-overlapping schedule every 4 weeks in combination with standard-dose ...

 


Onconova Announces Two Presentations at 2018 American Chemical Society National Meeting and Expo - GlobeNewswire (press release)



Onconova Announces Two Presentations at 2018 American Chemical Society National Meeting and Expo 
GlobeNewswire (press release)
Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). Rigosertib, Onconova's lead ...

and more » 


H3 Biomedicine Preclinical Proof-of-Concept Data on First-in-Class Spliceosome-Modulator Therapy for Genomically ... - Business Wire (press release)



H3 Biomedicine Preclinical Proof-of-Concept Data on First-in-Class Spliceosome-Modulator Therapy for Genomically ... 
Business Wire (press release)
Mutations in genes encoding for certain of these RNA splicing factors that form the spliceosome are among the most common mutations found in patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia ...

and more » 


Forum to Give Latest on MDS Treatment - Newswise (press release)



Forum to Give Latest on MDS Treatment 
Newswise (press release)
Myelodysplastic syndromes are a group of bone marrow disorders. Bone marrow is the soft spongy tissue inside certain human bones that creates blood cells. In MDS, the bone marrow does not produce enough healthy mature blood cells. People with MDS can ...

 


Free Public Forum to Give Latest on MDS Treatment - HSC Newsbeat



HSC Newsbeat
 
Free Public Forum to Give Latest on MDS Treatment 
HSC Newsbeat
The Myelodysplastic Syndromes (MDS) Foundation and The University of New Mexico Comprehensive Cancer Center are sponsoring a free public information forum for MDS patients, families and caregivers Tuesday, March 13, 9:30 a.m.-2 p.m., in the Embassy ...

 


What's in the Cards for Geron (GERN) This Earnings Season? - Nasdaq



Nasdaq
 
What's in the Cards for Geron (GERN) This Earnings Season? 
Nasdaq
Geron is developing imetelstat in collaboration with Johnson & Johnson's JNJ for treating patients with hematologic myeloid malignancies like myelofibrosis ("MF"), myelodysplastic syndromes ("MDS") and acute myelogenous leukemia ("AML"). Two late-stage ...

and more » 


Actinium Pharmaceuticals Announces Product Showcase and Other ... - GlobeNewswire (press release)



Actinium Pharmaceuticals Announces Product Showcase and Other ... 
GlobeNewswire (press release)
NEW YORK, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") announced today that representatives from the Company's executive and clinical development teams will be attending the BMT ...
Actinium Pharmaceuticals Announces Product Showcase and Other Visibility Extending Activities at the BMT Tandem ... Nasdaq

all 1 news articles » 


Beigene (NASDAQ:BGNE) Given ?Buy? Rating at Maxim Group - The Ledger Gazette



Beigene (NASDAQ:BGNE) Given ?Buy? Rating at Maxim Group 
The Ledger Gazette
Beigene logo Beigene (NASDAQ:BGNE)'s stock had its ?buy? rating reissued by research analysts at Maxim Group in a note issued to investors on Wednesday, February 7th. The analysts wrote, ?BeiGene announced the commercial availability of Celgene's ...

and more »